These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 26351937)

  • 1. mRNA overexpression of kallikrein-related peptidase 14 (KLK14) is an independent predictor of poor overall survival in chronic lymphocytic leukemia patients.
    Kontos CK; Adamopoulos PG; Papageorgiou SG; Pappa V; Scorilas A
    Clin Chem Lab Med; 2016 Feb; 54(2):315-24. PubMed ID: 26351937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KLKB1 mRNA overexpression: A novel molecular biomarker for the diagnosis of chronic lymphocytic leukemia.
    Adamopoulos PG; Kontos CK; Papageorgiou SG; Pappa V; Scorilas A
    Clin Biochem; 2015 Sep; 48(13-14):849-54. PubMed ID: 25891023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parallel overexpression and clinical significance of kallikrein-related peptidases 7 and 14 (KLK7KLK14) in colon cancer.
    Devetzi M; Trangas T; Scorilas A; Xynopoulos D; Talieri M
    Thromb Haemost; 2013 Apr; 109(4):716-25. PubMed ID: 23224034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mRNA overexpression of the hypoxia inducible factor 1 alpha subunit gene (HIF1A): An independent predictor of poor overall survival in chronic lymphocytic leukemia.
    Kontos CK; Papageorgiou SG; Diamantopoulos MA; Scorilas A; Bazani E; Vasilatou D; Gkontopoulos K; Glezou E; Stavroulaki G; Dimitriadis G; Pappa V
    Leuk Res; 2017 Feb; 53():65-73. PubMed ID: 28038356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated miR-20b-5p expression in peripheral blood mononuclear cells: A novel, independent molecular biomarker of favorable prognosis in chronic lymphocytic leukemia.
    Papageorgiou SG; Kontos CK; Tsiakanikas P; Stavroulaki G; Bouchla A; Vasilatou D; Bazani E; Lazarakou A; Scorilas A; Pappa V
    Leuk Res; 2018 Jul; 70():1-7. PubMed ID: 29715621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel, mitochondrial, internal tRNA-derived RNA fragment possesses clinical utility as a molecular prognostic biomarker in chronic lymphocytic leukemia.
    Karousi P; Adamopoulos PG; Papageorgiou SG; Pappa V; Scorilas A; Kontos CK
    Clin Biochem; 2020 Nov; 85():20-26. PubMed ID: 32745483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of KLK14 in prostatic adenocarcinoma is associated with elevated risk of prostate-specific antigen relapse.
    Rabien A; Fritzsche F; Jung M; Diamandis EP; Loening SA; Dietel M; Jung K; Stephan C; Kristiansen G
    Tumour Biol; 2008; 29(1):1-8. PubMed ID: 18497543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced high-grade serous ovarian cancer: inverse association of KLK13 and KLK14 mRNA levels in tumor tissue and patients' prognosis.
    Dettmar L; Ahmed N; Kotzsch M; Diersch S; Napieralski R; Darmoul D; Schmitt M; Weichert W; Kiechle M; Dorn J; Magdolen V
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1109-1118. PubMed ID: 29546479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiopoietin-2 mRNA expression is increased in chronic lymphocytic leukemia patients with poor prognostic features.
    Vrbacky F; Smolej L; Vroblova V; Pekova S; Hrudkova M; Cervinka M; Pecka M; Krejsek J; Maly J
    Hematology; 2010 Aug; 15(4):210-4. PubMed ID: 20670479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-92a-3p overexpression in peripheral blood mononuclear cells is an independent predictor of prolonged overall survival of patients with chronic lymphocytic leukemia.
    Papageorgiou SG; Diamantopoulos MA; Kontos CK; Bouchla A; Vasilatou D; Bazani E; Scorilas A; Pappa V
    Leuk Lymphoma; 2019 Mar; 60(3):658-667. PubMed ID: 29911923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of the deregulated kallikrein-related peptidase 8 mRNA expression in breast cancer: a novel independent indicator of disease-free survival.
    Michaelidou K; Ardavanis A; Scorilas A
    Breast Cancer Res Treat; 2015 Jul; 152(2):323-36. PubMed ID: 26099606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic Leukemia.
    Visentin A; Facco M; Frezzato F; Castelli M; Trimarco V; Martini V; Gattazzo C; Severin F; Chiodin G; Martines A; Bonaldi L; Gianesello I; Pagnin E; Boscaro E; Piazza F; Zambello R; Semenzato G; Trentin L
    Clin Lymphoma Myeloma Leuk; 2015 Oct; 15(10):612-20.e1-5. PubMed ID: 26233718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis.
    Yousef GM; Borgoño CA; Scorilas A; Ponzone R; Biglia N; Iskander L; Polymeris ME; Roagna R; Sismondi P; Diamandis EP
    Br J Cancer; 2002 Nov; 87(11):1287-93. PubMed ID: 12439719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FCRL2 mRNA expression is inversely associated with clinical progression in chronic lymphocytic leukemia.
    Nückel H; Collins CH; Frey UH; Sellmann L; Dürig J; Siffert W; Dührsen U
    Eur J Haematol; 2009 Dec; 83(6):541-9. PubMed ID: 19682311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel, internal tRNA-derived RNA fragment as a new prognostic and screening biomarker in chronic lymphocytic leukemia, using an innovative quantitative real-time PCR assay.
    Katsaraki K; Artemaki PI; Papageorgiou SG; Pappa V; Scorilas A; Kontos CK
    Leuk Res; 2019 Dec; 87():106234. PubMed ID: 31669784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker.
    Papageorgiou SG; Kontos CK; Pappa V; Thomadaki H; Kontsioti F; Dervenoulas J; Papageorgiou E; Economopoulos T; Scorilas A
    Oncologist; 2011; 16(9):1280-91. PubMed ID: 21737576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low mRNA expression levels of kallikrein-related peptidase 4 (KLK4) predict short-term relapse in patients with laryngeal squamous cell carcinoma.
    Foteinou E; Kontos CK; Giotakis AI; Scorilas A
    Biol Chem; 2014 Sep; 395(9):1051-62. PubMed ID: 24854539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of LPL gene expression in patients with chronic lymphocytic leukemia.
    Bilous N; Abramenko I; Chumak A; Dyagil I; Martina Z
    Exp Oncol; 2019 Mar; 41(1):39-45. PubMed ID: 30932419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor Prognosis.
    Papageorgiou SG; Kontos CK; Diamantopoulos MA; Bouchla A; Glezou E; Bazani E; Pappa V; Scorilas A
    Dis Markers; 2017; 2017():2046545. PubMed ID: 29463948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of ZAP70 mRNA in B cells by real-time PCR is a powerful prognostic factor in chronic lymphocytic leukemia.
    Stamatopoulos B; Meuleman N; Haibe-Kains B; Duvillier H; Massy M; Martiat P; Bron D; Lagneaux L
    Clin Chem; 2007 Oct; 53(10):1757-66. PubMed ID: 17702857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.